| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 02/22/2000 | US6028070 Treating oppositional defiant disorder comprising administration to a patient in need of such treatment an effective amount of a norepinephrine reuptake inhibitor selective for norepinephrine over other neurotransmitters |
| 02/22/2000 | US6028069 For treating or preventing arrhythmias, angina pectoris or infarcts comprising administering effective dosage to patient |
| 02/22/2000 | US6028068 Substituted 6H-1,3,4-thiadiazine-2-amines, the use thereof as anaesthetising, cardiovascular and hypometabolic agents, and a pharmaceutical composition containing them |
| 02/22/2000 | US6028064 Preventing ovarian cancer in post-menopausal female subject in need thereof who is no longer ovulating comprising administering to post-menopausal female subject progestin product sensitive to preventing ovarian cancer |
| 02/22/2000 | US6028063 Kappa agonist compounds, pharmaceutical formulations and method of prevention and treatment of pruritus therewith |
| 02/22/2000 | US6028062 Administering an effective amount of dimethicone to a patient in need thereof for 4 weeks |
| 02/22/2000 | US6028061 Angiogenesis inhibitors and use thereof |
| 02/22/2000 | US6028060 Treatment of chronic inflammatory diseases with CM101/GBS toxin |
| 02/22/2000 | US6028057 Inducing pseudopregnancy in fertile female pigs comprising administering to the pigs an effective amount of a compound that induces pseudopregnancy in a biodegradable controlled release formulation |
| 02/22/2000 | US6028052 Treating NIDDM with RXR agonists |
| 02/22/2000 | US6028051 Administering single dose of lysostaphin analogue and lysostaphin for treating endocarditis, bacterimia, kidney infection, lung infection, skin infection, bone infection, burn wound infections, infection of prosthetic devices |
| 02/22/2000 | US6027936 Carbon monoxide dependent guanyly cyclase modifiers and methods of use |
| 02/22/2000 | US6027905 Methods for the detection of cervical cancer |
| 02/22/2000 | US6027749 Pharmaceutical combined preparation, kit and method for hormonal contraception |
| 02/22/2000 | US6027747 Process for the production of dry pharmaceutical forms and the thus obtained pharmaceutical compositions |
| 02/22/2000 | US6027741 A biomedical object or device having a coating of a sulfated hyaluronic acid, ester of salt, wherein the number of sulfate groups per disaccharide unit is from 0.5-3.5; medical equipment; anticoagulants; cell abhesion; viricides; hiv |
| 02/22/2000 | US6027737 Orally administering a potassium salt of a carbohydrate or citrate which generates or is metabolized to the bicarbonate after ingestion and reduces acidity; sodium bicarbonate-free; improves calcium and phosphorus balances; nontoxic; |
| 02/22/2000 | US6027714 Formulation for inhalation |
| 02/22/2000 | US6027713 Composition and method for the treatment of exercise induced pulmonary hemorrhage |
| 02/22/2000 | US6026817 Method of treating the syndrome of coronary heart disease risk factors in humans |
| 02/22/2000 | CA2258095C Tetrahydrolipstatin containing compositions |
| 02/22/2000 | CA2208707C Novel aminooligosaccharide derivative and process for preparing the same |
| 02/22/2000 | CA2199614C Fused indole and quinoxaline derivatives, their preparation and use |
| 02/22/2000 | CA2170607C Difluoro statone antiviral analogs |
| 02/22/2000 | CA2164799C Compounds mode of an abrasive system and a surface-active system |
| 02/22/2000 | CA2157248C Crystalline form of dihydro-2, 3 benzodiazepine derivative |
| 02/22/2000 | CA2137395C 9a-n-(n'-carbamoyl) and 9a-n-(n' - thiocarbamoyl) derivatives of 9-deoxo-9a-aza-9a-homoerythromycin a |
| 02/22/2000 | CA2081356C Derivatives and analogues of 2-deoxy-2,3-didehydro-n- acetyl neuraminic acid and their use as antiviral agents |
| 02/22/2000 | CA2023563C Stable injectable pharmaceutical formulation for folic acid and leucovorin salts and method |
| 02/22/2000 | CA2002834C Cycloalkyl xanthines |
| 02/22/2000 | CA1340909C Purine derivatives and use thereof in therapy |
| 02/22/2000 | CA1340904C Amino acid derivative anticonvulsant |
| 02/22/2000 | CA1340902C Amino acid derivative anticonvulsant |
| 02/21/2000 | CA2420425A1 Growth hormone secretagogues |
| 02/21/2000 | CA2280596A1 New indan-1-ol derivatives, their preparation method, and pharmaceutical compositions containing them |
| 02/21/2000 | CA2244097A1 Pharmaceutical composition comprising bupropion hydrochloride and fumaric acid |
| 02/19/2000 | WO2000010390A1 Method of enhancing the antimicrobial properties of antibacterial antibiotics |
| 02/18/2000 | CA2280455A1 The use of aryl-cyclohexylamine derivatives against cns disorders |
| 02/17/2000 | WO2000008202A2 3-methylidenyl-2-indolinone modulators of protein kinase |
| 02/17/2000 | WO2000008193A2 Latency-active regulatory sequences of herpesviruses and latency-inactive herpesvirus for gene transfer |
| 02/17/2000 | WO2000008171A1 N-acetylglycosaminyl transferase genes |
| 02/17/2000 | WO2000008150A1 Method for treatment of invasive cells |
| 02/17/2000 | WO2000008144A1 Dna encoding a human inhibitor-of-apoptosis protein; hiap3 |
| 02/17/2000 | WO2000008141A2 Short oligonucleotides for the inhibition of vegf expression |
| 02/17/2000 | WO2000008140A2 Antisense oligonucleotides for the inhibition of vegf expression |
| 02/17/2000 | WO2000008139A1 Tumor necrosis factor-gamma |
| 02/17/2000 | WO2000008063A1 Process for producing cationic polymer |
| 02/17/2000 | WO2000008061A1 Reaction products of hyaluronic acid and natural amino acids and their use in cosmetic and pharmaceutical compositions |
| 02/17/2000 | WO2000008053A1 Novel g-protein coupled receptor protein and dna thereof |
| 02/17/2000 | WO2000008051A2 Immunological herpes simplex virus antigens and methods for use thereof |
| 02/17/2000 | WO2000008044A1 2'-o-aminoethyloxyethyl-modified oligonucleotides |
| 02/17/2000 | WO2000008042A1 Aminooxy-modified nucleosidic compounds and oligomeric compounds prepared therefrom |
| 02/17/2000 | WO2000008033A1 Water soluble prodrugs of hindered alcohols or phenols |
| 02/17/2000 | WO2000008031A1 Novel phospholipids with unsaturated alkyl and acyl chains |
| 02/17/2000 | WO2000008025A1 Synthesis of acyclic nucleoside derivatives |
| 02/17/2000 | WO2000008024A1 Substituted imidazo[1,2a]azines as selective inhibotors of cox-2 |
| 02/17/2000 | WO2000008021A2 Process for preparing n,n,6- trimethyl-2 -(4-methylphenyl)- imidazo-[1,2-a] -pyridine-3- acetamide and salts thereof |
| 02/17/2000 | WO2000008020A2 Tricyclic carboxamides |
| 02/17/2000 | WO2000008017A1 Process for the preparation of a non-crystalline anhydrate form of paroxetine hydrochloride |
| 02/17/2000 | WO2000008015A2 Fsh mimetics for the treatment of infertility |
| 02/17/2000 | WO2000008014A1 Disubstituted bicyclic heterocycles having, in particular, a thrombin inhibitive effect |
| 02/17/2000 | WO2000008013A2 2-substituted-1-piperidyl benzimidazole compounds as orl1-receptor agonists |
| 02/17/2000 | WO2000008007A2 Cyclopentabenzofuran derivatives and their use |
| 02/17/2000 | WO2000008006A2 Piperidine and piperazine derivatives, process for their preparation and pharmaceutical compounds containing them |
| 02/17/2000 | WO2000008004A1 Particle-forming compositions containing fused pyrrolocarbazoles |
| 02/17/2000 | WO2000008002A1 SUBSTITUTED OXAZOLES AND THIAZOLES DERIVATIVES AS hPPAR GAMMA AND hPPAR ALPHA ACTIVATORS |
| 02/17/2000 | WO2000008001A1 Substituted isoxazole as estrogen receptor modulators |
| 02/17/2000 | WO2000007997A1 IMIDAZOLES AND RELATED COMPOUNDS AS α1A AGONISTS |
| 02/17/2000 | WO2000007996A2 Pyrazoles as estrogen receptor modulators |
| 02/17/2000 | WO2000007995A1 SUCCINOYLAMINO LACTAMS AS INHIBITORS OF Aβ PROTEIN PRODUCTION |
| 02/17/2000 | WO2000007994A1 Novel bi- and tri-cyclic aza compounds and their uses |
| 02/17/2000 | WO2000007991A1 Amide derivatives useful as inhibitors of the production of cytokines |
| 02/17/2000 | WO2000007988A1 New 4-amino-1-aryl-pyridine-2-ones with anticonvulsive action and method for producing same |
| 02/17/2000 | WO2000007987A1 Crystalline forms of osanetant |
| 02/17/2000 | WO2000007986A1 Novel 2,3,3a,4,9,9a hexahydro-8-hydroxy-1h-benz[f]indoles, a method for the production thereof, and their use as medicaments |
| 02/17/2000 | WO2000007984A1 A process for the preparation of zofenopril calcium salt |
| 02/17/2000 | WO2000007980A1 Amide derivatives which are useful as cytokine inhibitors |
| 02/17/2000 | WO2000007979A2 Compounds and compositions for delivering active agents |
| 02/17/2000 | WO2000007978A1 Aminomethylcarboxylic acid derivatives |
| 02/17/2000 | WO2000007977A1 Novel phenylethylamine derivatives, a method for the production thereof and their use as medicaments |
| 02/17/2000 | WO2000007974A1 2-fluoro mutilin derivatives |
| 02/17/2000 | WO2000007972A1 Glucocorticoid and thyroid hormone receptor ligands for the treatment of metabolic disorders |
| 02/17/2000 | WO2000007629A2 Peg-urate oxidase conjugates and use thereof |
| 02/17/2000 | WO2000007628A1 STABILIZED PREPARATIONS OF β-LACTAM ANTIBIOTIC |
| 02/17/2000 | WO2000007627A2 Topical delivery systems for active agents |
| 02/17/2000 | WO2000007624A2 Pharmaceutical composition having inhibitory effect on overproduction and accumulation of extracellular matrix |
| 02/17/2000 | WO2000007614A1 Remedies for nerve degeneration diseases |
| 02/17/2000 | WO2000007608A1 COMPOSITION AND METHOD OF TREATING DISEASE WITH EXTRACT OF $i(MUSACEAS) |
| 02/17/2000 | WO2000007607A1 Nutrient and therapeutic compositions for the treatment of cancer |
| 02/17/2000 | WO2000007605A1 Use of camptothecin derivatives, with reduced gastrointestinal toxicity |
| 02/17/2000 | WO2000007604A1 Prostate formula |
| 02/17/2000 | WO2000007602A1 Compounds for altering cell surface sialic acids and methods of use therefor |
| 02/17/2000 | WO2000007601A1 Ophtalmic solution with tetracycline for topical treatment of dry eye disease |
| 02/17/2000 | WO2000007600A1 Pharmaceutical compositions for the prevention and treatment of central nervous system disorders |
| 02/17/2000 | WO2000007599A1 Prevention of endometriosis signs or symptoms |
| 02/17/2000 | WO2000007598A1 Use of a nk-1 receptor antagonist for treating or preventing abnormal bone resorption |
| 02/17/2000 | WO2000007597A1 Transmucosal therapeutic system for administering sildenafil |
| 02/17/2000 | WO2000007596A1 Water-soluble pharmaceutical formulation for administering sildenafil |
| 02/17/2000 | WO2000007595A1 Pyridinones for the treatment of sexual dysfunction |
| 02/17/2000 | WO2000007594A1 Use of il-2 inhibitors in the treatment of rheumatoid arthritis |